Semra Paydas
Overview
Explore the profile of Semra Paydas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
1538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozyurt N, Alkan A, Gulbagci B, Seyyar M, Asik E, Sahbazlar M, et al.
Sci Rep
. 2024 Oct;
14(1):23556.
PMID: 39384975
The studies evaluating the impact of Her2 levels in neoadjuvant setting have conflicting data. The aim of the study was to evaluate the prognostic impact of Her2 status in early...
2.
Mehtap O, Toptas T, Dal M, Keklik Karadag F, Atas U, Ozsan G, et al.
Leuk Lymphoma
. 2024 Sep;
65(14):2190-2198.
PMID: 39269267
Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study was to develop a PS system for these...
3.
Bayram E, Pehlivan U, Erdogan K, Turker M, Yalniz H, Paydas S
Oncol Lett
. 2024 Sep;
28(5):516.
PMID: 39268169
Soft tissue sarcomas are rare cancers and most cases are metastatic at the time of diagnosis. Although the chances of survival are good with surgical treatment in the early stages,...
4.
Karadurmus N, Kaplan M, Sendur M, Urun Y, Demirci U, Karaca S, et al.
Curr Med Res Opin
. 2024 May;
40(7):1171-1178.
PMID: 38809230
Objective: To evaluate the efficacy and safety of nivolumab in the second-line (2L) or later-line (LL) treatment of patients with locally advanced/metastatic non-small cell lung cancer (NSCLC) in real-life setting...
5.
Kilickap S, Ozturk A, Karadurmus N, Korkmaz T, Yumuk P, Cicin I, et al.
Medicine (Baltimore)
. 2024 May;
103(21):e37972.
PMID: 38787994
To evaluate radiological and clinical features in metastatic anaplastic lymphoma kinase+ non-small cell lung cancer patients and crizotinib efficacy in different lines. This national, non-interventional, multicenter, retrospective archive screening study...
6.
Yasar H, Aktas B, Ucar G, Sezgin Goksu S, Bilgetekin I, Cakar B, et al.
Clin Genitourin Cancer
. 2024 Apr;
22(3):102077.
PMID: 38626660
Introduction: Adrenocortical carcinoma (ACC) is a rare yet highly malignant tumor associated with significant morbidity and mortality. This study aims to delineate the clinical features, survival patterns, and treatment modalities...
7.
Yetisir A, Paydas S, Buyuksimsek M, Ogul A, Kolsuz I, Kidi M
J Cancer Res Ther
. 2024 Mar;
20(1):285-288.
PMID: 38554335
Background: To evaluate the relationship of overall survival (OS) and progression-free survival (PFS) with the derived neutrophil-lymphocyte ratio (dNLR), neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), and platelet-lymphocyte ratio (PLR) in...
8.
Khatib G, Seyfettinoglu S, Kose S, Kucukgoz Gulec U, Avci A, Guzel A, et al.
Int J Gynecol Cancer
. 2023 Nov;
34(1):122-130.
PMID: 37945055
Objective: Primary debulking surgery has been the preferred surgical route and is still considered a quality indicator for advanced ovarian cancer surgery. However, a significant number of patients are not...
9.
Bayram E, Toyran T, Guney B, Uguz A, Gumurdulu D, Paydas S
Med Int (Lond)
. 2023 Nov;
3(6):57.
PMID: 37927354
Lung cancer is a common malignancy that has usually already metastasized at the time of diagnosis; however, thyroid metastases are extremely rare. Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (ALK) fusion...
10.
Unal C, Azizy A, Karabulut S, Tastekin D, Akyildiz A, Yasar S, et al.
Oncologist
. 2023 Sep;
28(10):875-884.
PMID: 37676712
Introduction: This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in patients with metastatic neuroendocrine tumors (NETs). Methods: We conducted...